lifestyle.thedishh.com

Author: Keros Therapeutics, Inc.

Keros Therapeutics Reports Recent First Quarter 2026 Financial Results

May 14, 2026
Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference

March 9, 2026
Keros Therapeutics Announces Collaboration with Sean M. Healey & AMG Center for ALS

March 9, 2026
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

March 5, 2026
Keros Therapeutics Appoints Charles Newton to its Board of Directors

February 26, 2026
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

February 18, 2026